NIH Funding Slump: Research Projects on Hold

The National Institutes of Health (NIH), a primary funder of medical research, is experiencing a substantial delay in awarding new grants, reportedly falling about $1 billion behind its usual schedule. Between October and late March, fewer than half of the typical number of competitive grants were approved.

This funding bottleneck is hindering a wide array of critical scientific endeavors, including research into cancer, heart disease, and Alzheimer's. For instance, the National Cancer Institute has significantly less funding allocated for new research grants compared to previous years.

Several factors have converged to create this funding slump. A government shutdown last fall caused months-long delays for essential review meetings. Concurrently, the NIH has seen thousands of staff departures, reducing the workforce available to process grant applications.

An additional layer of complexity involves a new review step using a computational text analysis tool that scans proposals for specific terms related to agency priorities. Proposals flagged by this tool may be delayed as researchers revise them.

While a spokesperson for the U.S. Department of Health and Human Services indicated that funding timelines are returning to normal patterns and all appropriated funds are intended for obligation, some scientists remain concerned about the lost time and its implications for scientific progress and potential discoveries.